Immediate Impact
1 from Science/Nature 31 standout
Citing Papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Chimeric antigen receptor T cell therapy for autoimmune disease
2024 Standout
Works of Norbert Grobe being referenced
A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010–2012
2015
Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Norbert Grobe | 44 | 22 | 51 | 43 | 9 | 104 | |
| Jehane Fadlallah | 16 | 14 | 36 | 52 | 11 | 101 | |
| Ben Mulhearn | 78 | 13 | 24 | 11 | 11 | 136 | |
| Frédérique Caillot | 35 | 19 | 38 | 10 | 8 | 129 | |
| Élodie Constant | 193 | 57 | 32 | 15 | 9 | 225 | |
| Jean-Pierre David | 26 | 9 | 13 | 52 | 9 | 175 | |
| Pierre‐Edouard Gavand | 112 | 6 | 20 | 8 | 8 | 139 | |
| Peigen He | 83 | 17 | 17 | 14 | 8 | 142 | |
| James Krell | 28 | 3 | 45 | 57 | 10 | 196 | |
| G.M. Mead | 34 | 29 | 44 | 47 | 12 | 175 | |
| Amy D Greenway | 16 | 8 | 31 | 94 | 9 | 161 |
All Works
Loading papers...